Cognitive improvement after mild traumatic brain injury measured with functional neuroimaging during the acute period
The article,
Cognitive improvement after mild traumatic brain injury measured with functional neuroimaging during the acute period, was published by PLoS One (doi: 10.137 / journal.pone.0126110).
Not exact matches
All three groups showed some
improvement on
cognitive measures when assessed
after the ten weeks, says Dr. Caryn Lerman, the study's lead author and a psychiatry professor at the University of Pennsylvania.
After undergoing the complex process, nine of the 10 participants, who suffered from
cognitive impairment or memory loss associated with Alzheimer's, displayed
improvement in memory three to six months into the program — a joint venture between the Mary S. Easton Center for Alzheimer's Disease Research at UCLA and the Buck Institute for Research on Aging.
The researchers measured significant
improvements in children's
cognitive skills
after the intervention.
Abstract: Sustained long - term
improvement in clinical and
cognitive outcomes
after fecal microbiota transplantation in cirrhosis (3161)
The original, randomized, open label study, which enrolled 20 outpatient men with cirrhosis and recurrent HE receiving standard - of - care (SOC) treatment, had previously reported that a single FMT enema
after antibiotic pretreatment improved
cognitive function at Day 20 and reduced HE episodes and hospitalizations over the following 5 months compared with SOC.1 The long - term outcomes of this study, which were presented today at The International Liver Congress ™ 2018 in Paris, France, demonstrated sustained and statistically significant reductions in the number of HE episodes and hospitalizations as well as
improvements in
cognitive function over 1 year in the men who received FMT compared with the control group.
After training, only the gist - reasoning group showed significant
improvement in the ability to abstract meanings — a foundational
cognitive skill to everyday life functionality.
After 90 days though everyone pretty much evened out in
cognitive improvement which does not show any real gain.
A study done in patients with Alzheimer's disease showed the
improvement of
cognitive function only 90 minutes
after receiving a drink that contained medium chained triglycerides, when compared to a placebo (8).
Using standard
cognitive tests, we measured attention, impulsivity and working memory before and
after one month of at - home interaction with the device, and found statistically significant
improvements in these 3 areas, and especially large
improvements for children with substantially higher attention impairment at the beginning of the study.
Of the 69 dogs with
cognitive dysfunction mentioned above, approximately 76 percent showed
improvement on selegiline hydrochloride
after one month of therapy.
When using L - Deprenyl to treat
cognitive dysfunction, if no
improvement is seen
after the first month, your veterinarian may recommend doubling the dose for an additional month before deciding the drug may not be useful in that particular pet.
About 75 % of dogs will show some
improvement in
cognitive ability
after one month of Selegiline, although significant
improvement in one specific symptom may not be adequate to justify its continued use.
Studies using Anipryl ® for the treatment of CDS have shown that
after 30 days, 80 % of dogs showed
improvement in overall
cognitive response compared to pretreatment evaluation and
improvements in individual clinical signs also were observed.
Clinical
improvement with
cognitive behaviour therapy may be slow but often continues
after treatment has ended
A recent randomised controlled trial gave evidence for the effectiveness of
cognitive behaviour therapy, but only 60 % of the adolescents had made a complete recovery as assessed directly
after treatment.13 In an uncontrolled study of the effectiveness of family
cognitive behaviour therapy, 83 % improved, and this
improvement lasted for the follow up time of six months.14 Multidisciplinary rehabilitative treatment was shown to be effective in another uncontrolled study, 15 but only 43 % had complete recovery.
The
improvement in day to day functioning in the group who received
cognitive behaviour therapy continued
after treatment had ended.
Our finding that the severity of depressive symptoms was a significant but relatively smaller contributor to physical disability in this sample (
after controlling for the possible effects of age, sex and duration of pain) is consistent with findings of some previous studies of patients with chronic pain, but not with some treatment studies, which found that depression level contributed to less significant
improvement in pain - related disability.11, 27 It is not surprising that
cognitive, pain and behavioural variables accounted for more physical disability than depressive symptoms but it is notable that social support (as measured by the MPI), sense of control over life, and catastrophising did not significantly contribute to physical disability.
Improvement in social - interpersonal functioning
after cognitive therapy for recurrent depression